Bildkälla: Stockfoto

Amniotics: approval to start phase I/II - Redeye

Redeye is encouraged by today’s news that Amniotic’s phase I/II trial with Pulmostem has been approved by the regulatory authorities.

Redeye is encouraged by today’s news that Amniotic’s phase I/II trial with Pulmostem has been approved by the regulatory authorities.
Börsvärldens nyhetsbrev
ANNONSER